[{"data":1,"prerenderedAt":133},["ShallowReactive",2],{"naujienos/lithuanians-developed-home-medical-device-for-early-heart-condition-diagnosis/en":3},{"status":4,"data":5},true,{"image":6,"id":13,"seo":14,"title":11,"date":88,"url":84,"fullUrl":25,"text":89,"excerpt":24,"more":90,"tags":131,"temos":132},{"src":7,"is_svg":8,"ratio":9,"width":10,"height":10,"alt":11,"caption":12},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2024/01/zive-ekg-8-1.jpg",false,1,3000,"Lithuanians developed home medical device for early heart condition diagnosis","",6867,{"title":15,"robots":16,"og_locale":22,"og_type":23,"og_title":15,"og_description":24,"og_url":25,"og_site_name":26,"article_publisher":27,"og_image":28,"twitter_card":32,"schema":33,"breadcrumbs":76,"description":12,"language":85},"Lithuanians developed home medical device for early heart condition diagnosis - Inovacijų agentūra",{"index":17,"follow":18,"max-snippet":19,"max-image-preview":20,"max-video-preview":21},"index","follow","max-snippet:-1","max-image-preview:large","max-video-preview:-1","en_US","article","Lithuanian medical company called Zive successfully implemented the project “Long-term heart monitoring artificial intelligence HEART AI” for early diagnosis of heart conditions. In the course of the project, smart devices providing cardiological diagnosis and prevention tools for home use, while the artificial intelligence fitted in them enables effective analysis of received data and provision of doctors with valuable information.","https://www.inovacijuagentura.lt/en/naujiena/lithuanians-developed-home-medical-device-for-early-heart-condition-diagnosis/","Inovacijų agentūra","https://www.facebook.com/inovacijuagentura",[29],{"width":30,"height":30,"url":7,"type":31},"3000","image/jpeg","summary_large_image",{"@context":34,"@graph":35},"https://schema.org",[36,51,53,63,67],{"@type":37,"@id":25,"url":25,"name":15,"isPartOf":38,"primaryImageOfPage":40,"image":42,"thumbnailUrl":7,"datePublished":43,"breadcrumb":44,"inLanguage":46,"potentialAction":47},"WebPage",{"@id":39},"https://www.inovacijuagentura.lt/en/#website",{"@id":41},"https://www.inovacijuagentura.lt/en/naujiena/lithuanians-developed-home-medical-device-for-early-heart-condition-diagnosis/#primaryimage",{"@id":41},"2024-01-09T20:00:00+00:00",{"@id":45},"https://www.inovacijuagentura.lt/en/naujiena/lithuanians-developed-home-medical-device-for-early-heart-condition-diagnosis/#breadcrumb","en-US",[48],{"@type":49,"target":50},"ReadAction",[25],{"@type":52,"inLanguage":46,"@id":41,"url":7,"contentUrl":7,"width":30,"height":30,"caption":11},"ImageObject",{"@type":54,"@id":45,"itemListElement":55},"BreadcrumbList",[56,61],{"@type":57,"position":58,"name":59,"item":60},"ListItem","1","Home","https://www.inovacijuagentura.lt/en/",{"@type":57,"position":62,"name":11},"2",{"@type":64,"@id":39,"url":60,"name":26,"description":12,"publisher":65,"inLanguage":46},"WebSite",{"@id":66},"https://www.inovacijuagentura.lt/en/#organization",{"@type":68,"@id":66,"name":26,"url":60,"logo":69,"image":74,"sameAs":75},"Organization",{"@type":52,"inLanguage":46,"@id":70,"url":71,"contentUrl":71,"width":72,"height":73,"caption":26},"https://www.inovacijuagentura.lt/en/#/schema/logo/image/","https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/05/ia-logo-main.svg","1886","786",{"@id":70},[27],[77,80,83],{"url":78,"text":59,"id":79},"/en/",7576,{"url":81,"text":82},"/en/news/","News",{"url":84,"text":11,"id":13},"/en/naujiena/lithuanians-developed-home-medical-device-for-early-heart-condition-diagnosis/",[86],{"url":25,"code":87,"locale":87,"default":8},"en","2024-01-09","\u003Cp style=\"text-align:justify\">The company benefited from the Experiment measure of the Innovation Agency, which was aimed to promote research, development and innovations (RDI). \u003C/p>\n\u003Cp style=\"text-align:justify\">According to Jekaterina Kalinienė, Head of BioTech Lab of the Innovation Agency, the Zive's project is an innovation of great importance in the fields of medicine and technologies. \u003C/p>\n\u003Cp style=\"text-align:justify\">“It is an excellent example how innovations can combine medicine with high technology solutions to improve the quality of life for patients and to contribute to healthy society formation. The devices developed in the framework of the project can help analysing big volumes of data, providing valuable information and recommendations to deal with complex health matters,” says the expert. \u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cstrong>The biotechnology sector is growing at double-digit rates \u003C/strong>\u003C/p>\n\u003Cp style=\"text-align:justify\">According to her, innovative technologies and solutions like these can become not just a part of health care services but also create new business fields, attract investments, and help Lithuania to take the leader's position in biotechnology field. \u003C/p>\n\u003Cp style=\"text-align:justify\">“Biotech sector is one of the priority sectors of the Lithuanian economy with highly ambitious strategic goals set for it. Upon achievement of which, we could become one of the leading countries in this field. In general, our country is nearly the only EU Member State enjoying the growth of the biotech sector at double-digit rates for nearly a decade – around 90 per cent of the Lithuanian products is exported to over 100 countries, and the largest biotechnology markets of the Lithuanian sector are the USA, Germany and United Kingdom', says Ms. Kalinienė. \u003C/p>\n\u003Cp style=\"text-align:justify\">According to the Head of BioTech Lab of the Innovation Agency, the Zive project not only contributes to the growth of the Lithuanian biotechnology ecosystem but also sets an inspiring example for other gifted researchers of our country: “Knowing that your work can have practical application value can be a  strong motivational factor. It encourages strengthening connections between scientific research and business, which bring benefits for both sides.” \u003C/p>\n\u003Cp style=\"text-align:justify\">\u003Cstrong>The product stands out on the market \u003C/strong>\u003C/p>\n\u003Cp style=\"text-align:justify\">Head of Technologies of Zive company Ignas Griškevičius says that anyone will be able to use heart monitoring devices – no special knowledge will be needed, and the devices are developed to be unnoticeable and not interfering with daily chores.  \u003C/p>\n\u003Cp style=\"text-align:justify\">“The device is easily mounted to the chest and does not interfere with daily life – a person can work, do sports, rest and sleep. The Zive cardiograph makes no sound and does not vibrate, therefore, it is unnoticeable by others, does not prevent from taking part in events or be in the environment where you have no wish to discuss your health. This way the device can monitor heart in real life without changing daily habits,” says Mr. Girškevičius and adds that the product already stands out from other similar items on the market for being certified as Class II medical device. \u003C/p>\n\u003Cp style=\"text-align:justify\">When talking about the challenges faced in the course of the project, the head of technology of the company points out a lack of accredited European Union institutions that can certify medical devices and of investing environment in Lithuania. “Our country does not have any institutions that are EU accredited to certify medical devices, therefore, the Zive devices were certified in TUV Rheniland certification centre in Germany, which took a lot of time and cost a considerable amount of funds.    \u003C/p>\n\u003Cp style=\"text-align:justify\">Besides, the investing environment in Lithuania is not favourable for the development of medical devices, since we do not have many specialists, investors are not willing to wait 3-5 years for a device to be developed and all necessary certificates to be obtained for placement on the market. Therefore, we are happy that the Innovation Agency trusted our idea and specialists – that was the crucial support in the development of the device and software'. \u003C/p>\n\u003Cp style=\"text-align:justify\">According to Mr. Griškevičius, the key goal of the project is to help people to have a healthy life, to prevent serious heart diseases, and focus the society on prevention and early diagnosis. \u003C/p>\n\u003Cp style=\"text-align:justify\">“To achieve these goals we have not only to get established in Lithuania and neighbour countries but also to expand to other markets. These are the long-term plans of this project,” says the Head of Technology of the medical company. \u003C/p>\n\u003Cp style=\"text-align:justify\">At the invitation of the Innovation Agency, the project received financing from the European Regional Development Fund under the Experiment measure of the first priority – Promotion of Research, Development and Innovations (RDI).  \u003C/p>\n\u003Cp style=\"text-align:justify\">Its purpose is to promote companies to invest into RDI needed for development of innovative products, services or processes, and to promote corporate development through investment into RDI and creation and development of the structure of innovations. \u003C/p>\n\u003Cp style=\"text-align:justify\"> \u003C/p>\n",[91,100,109,123],{"image":92,"title":95,"url":96,"id":97,"text":98,"temos":99},{"src":93,"is_svg":8,"ratio":94,"alt":95,"caption":12},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/05/kosmoso-memorandumas-su-polsa.jpg",0.6669921875,"Lithuania Strengthens Cooperation with Poland and the United States in the Space Sector: Important Memorandums Signed","/en/naujiena/lithuania-strengthens-cooperation-with-poland-and-the-united-states-in-the-space-sector-important-memorandums-signed/",6748,"Lithuania’s space sector continues to strengthen international partnerships and expand cooperation with key players in the global space industry. Innovation Agency Lithuania has recently signed two significant memorandums of understanding – with the Polish Space Agency (POLSA) and the U.S. space infrastructure company Vast. These agreements open new opportunities for Lithuanian businesses, research institutions, and international projects.",[],{"image":101,"title":104,"url":105,"id":106,"text":107,"temos":108},{"src":102,"is_svg":8,"ratio":103,"alt":104,"caption":12},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/03/shutterstock-2539768243-1.jpg",0.7490234375,"Lithuania Ranks First in Europe in the Global Entrepreneurship Index","/en/naujiena/lithuania-ranks-first-in-europe-in-the-global-entrepreneurship-index/",6892,"The latest Global Entrepreneurship Monitor (GEM) 2025/2026 global report shows that Lithuania is the leading country in Europe in terms of the quality of its entrepreneurial environment and ranks among the world’s strongest economies in this field.",[],{"image":110,"title":112,"url":113,"id":114,"text":115,"temos":116},{"src":111,"is_svg":8,"ratio":94,"alt":112,"caption":12},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/01/karolina-urbonaite.jpg","Lithuania’s Startup Ecosystem Surpasses €16.4 Billion in Value: Investments Jump 1.7x in 2025","/en/naujiena/lithuanias-startup-ecosystem-surpasses-e16-4-billion-in-value-investments-jump-1-7x-in-2025/",6999,"The total value of Lithuania’s startup ecosystem reached €16.4 billion in 2025, according to the latest Dealroom report initiated by Startup Lithuania, a division of the Innovation Agency. In just one year, Lithuanian startups attracted €220 million in venture capital investments from 77 unique investors. The ecosystem’s growing maturity was further confirmed earlier this year with the addition of a new unicorn to Lithuania’s startup map — Cast AI.",[117,120],{"id":118,"name":119},577,"Growth",{"id":121,"name":122},579,"Innovation",{"image":124,"title":126,"url":127,"id":128,"text":129,"temos":130},{"src":125,"is_svg":8,"ratio":94,"alt":126,"caption":12},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2025/12/modix-fgf-3d-spausdintuvas-2.jpg","Mission-Driven Innovations: Science and Business Shaping Lithuania’s Future","/en/naujiena/mission-driven-innovations-science-and-business-shaping-lithuanias-future/",6904,"Some important scientific research activities and innovative business-developed products may sound complex – unsurprisingly, as they are developed by people who dedicate their entire lives to these fields. Yet behind these sophisticated terms lie concrete solutions that will eventually make each of our daily lives easier. Where science and business join forces, more accurate disease diagnostics for the health of us and our loved ones are developed, cybersecurity tools are created to protect the country, and climate-neutral production technologies and materials emerge to help preserve our nature and resources.",[],[],[],1780325203310]